Biogen, Inc. (BIIB)
192.95
+1.58
(+0.83%)
USD |
NASDAQ |
May 15, 16:00
192.80
-0.15
(-0.08%)
After-Hours: 20:00
Biogen EPS Diluted (Quarterly) : 2.153 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Gilead Sciences, Inc. | 1.612 |
| AbbVie, Inc. | 0.3861 |
| Apellis Pharmaceuticals, Inc. | 0.142 |
| Moderna, Inc. | -3.40 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 319.50M |
| Revenue (Quarterly) | 2.403B |
| Total Expenses (Quarterly) | 2.084B |
| Enterprise Value | 30.77B |
| Gross Profit Margin (Quarterly) | 63.99% |
| Profit Margin (Quarterly) | 13.29% |
| Earnings Yield | 4.83% |
| Operating Earnings Yield | 8.07% |
| Normalized Earnings Yield | 5.882 |